A palladium(II)–saccharinate complex of terpyridine exerts higher anticancer potency and less toxicity than cisplatin in a mouse allograft model-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A palladium(II)–saccharinate complex of terpyridine exerts higher anticancer potency and less toxicity than cisplatin in a mouse allograft model

Published:2017-09 Issue:8 Volume:28 Page:898-910
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Cetin Yuksel,Adiguzel Zelal,Polat Hivda U.,Akkoc Tolga,Tas Arzu,Cevatemre Buse,Celik Gokalp,Carikci Baris,Yilmaz Veysel T.,Ulukaya Engin,Acilan Ceyda

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference37 articles.

1. Status of bi- and multi-nuclear platinum anticancer drug development;Zhang;Anticancer Agents Med Chem,2010

2. Clinical development of platinum complexes in cancer therapy: An historical perspective and an update;Lebwohl;Eur J Cancer,1998

3. Cisplatin as an anti-tumor drug: Cellular mechanisms of activity, drug resistance and induced side effects;Florea;Cancers (Basel,2011

4. Toxicity of platinum compounds;Hartmann;Expert Opin Pharmacother,2003

5. New-generation platinum agents for solid tumors;Shah;Future Oncol,2009

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metal complexes of saccharin and thiosaccharin as potential anticancer and antimicrobial agents;European Journal of Medicinal Chemistry Reports;2024-12

2. Pd(II) and Pt(II) saccharinate complexes with two phosphine derivatives: Synthesis, anticancer and antiangiogenic activities;Applied Organometallic Chemistry;2024-03-05

3. Modulation of the Cytotoxic Properties of Pd(II) Complexes Based on Functionalized Carboxamides Featuring Labile Phosphoryl Coordination Sites;Pharmaceutics;2023-03-28

4. Recent Advances of Metal-Based Anticancer Agents and Their In Vivo Potential Against Various Types of Malignancies;Handbook of Animal Models and its Uses in Cancer Research;2023

5. Dual LSD1 and HDAC6 Inhibition Induces Doxorubicin Sensitivity in Acute Myeloid Leukemia Cells;Cancers;2022-12-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3